Ipamorelin Sublingual Tablets

Description Ipamorelin CAS number 170851-70-4 Molar Mass 711.868 g·mol−1 Chemical Formula C38H49N9O5 IUPAC Name (2S)-6-Amino-2-[[(2R)-2-[[(2R)-2-[[(2S)-2-[(2-amino-2-methylpropanoyl)amino]-3-(4H-imidazol-4-yl)propanoyl]amino]-3-naphthalen-2-ylpropanoyl]amino]-3-phenylpropanoyl]amino]hexanamide Introduction Ipamorelin is a peptide known for its research applications in the field of endocrinology and metabolism. As a growth hormone secretagogue, it has garnered attention for its potential impact on various physiological processes. It is essential to note that Ipamorelin Vials are strictly intended for research purposes and are not for human consumption. Key Characteristics Ipamorelin Sublingual Tablets contain the synthetic peptide Ipamorelin, a growth hormone-releasing pentapeptide. This peptide stimulates the release of growth hormone without affecting cortisol levels, making it a unique and valuable tool for research endeavors. Note: Researchers may also explore related compounds such as the Sermorelin-Ipamorelin Blend, often studied for its combined effect on growth hormone pathways. The Ipamorelin Nasal Spray provides an alternative format for laboratory use, while the Ipamorelin Peptide is available as a single-agent option for focused research. Research Applications Researchers utilize Ipamorelin Sublingual Tablets to investigate the intricate mechanisms involved in growth hormone regulation, metabolism, and related pathways. The controlled and precise nature of Ipamorelin’s action makes it an invaluable asset in various experimental settings. Research Benefits Ipamorelin and Weight Gain Studies suggest that Ipamorelin may play a role in regulating body weight by promoting the release of growth hormone, which in turn may influence metabolism. Researchers are exploring its potential implications for understanding and addressing weight gain and related metabolic processes. Ipamorelin and Bone Health Research indicates that Ipamorelin may have positive effects on bone health by stimulating the release of growth hormone, which is crucial for bone growth and density. Investigations in this area aim to shed light on the potential applications of Ipamorelin in promoting bone health. Ipamorelin and Glucocorticoids In research settings, Ipamorelin is being studied for its interactions with glucocorticoids, a class of steroid hormones involved in various physiological processes. Exploring the interplay between Ipamorelin and glucocorticoids provides valuable insights into endocrine regulation and related health implications. Summary Ipamorelin Sublingual Tablets offer a controlled and targeted approach to studying growth hormone regulation and its impact on various physiological processes. The peptide’s unique characteristics make it a valuable tool in research applications focused on weight gain, bone health, and interactions with glucocorticoids. It is imperative to emphasize that Ipamorelin Vials are intended strictly for research purposes and are not suitable for human consumption. Disclaimer This content is presented exclusively for educational purposes and should not be construed as medical advice. THE MATERIALS REFERENCED HEREIN ARE EXCLUSIVELY INTENDED FOR LABORATORY AND RESEARCH USE. Any clinical research initiatives must be conducted under the guidance of the relevant Institutional Review Board (IRB). Similarly, preclinical research involving animals must comply with the directives of the Institutional Animal Care and Use Committee (IACUC), adhering to the standards delineated by the Animal Welfare Act (AWA). Our informational content is meticulously designed for research-oriented insights and is not a substitute for individual analysis and verification from credible sources before any purchasing decisions are made. Upon finalizing your order and payment, you explicitly acknowledge and agree to adhere to our Terms and Conditions. Customer satisfaction stands as our paramount concern. If you are dissatisfied with the product received, kindly contact us at 419-707-5450 or email our support team at [email protected]. IMPORTANT NOTICE: All products showcased on our platform are EXCLUSIVELY INTENDED FOR LABORATORY AND RESEARCH APPLICATIONS. They are expressly not intended for veterinary or human utilization. References Lall S, Tung LY, Ohlsson C, Jansson JO, Dickson SL. Growth hormone (GH)-independent stimulation of adiposity by GH secretagogues. Biochem Biophys Res Commun. 2001 Jan 12;280(1):132-8. doi: 10.1006/bbrc.2000.4065. PMID: 11162489. [Read More] Svensson J, Lall S, Dickson SL, Bengtsson BA, Rømer J, Ahnfelt-Rønne I, Ohlsson C, Jansson JO. The GH secretagogues ipamorelin and GH-releasing peptide-6 increase bone mineral content in adult female rats. J Endocrinol. 2000 Jun;165(3):569-77. doi: 10.1677/joe.0.1650569. PMID: 10828840. [Read More] Johansen PB, Nowak J, Skjaerbaek C, Flyvbjerg A, Andreassen TT, Wilken M, Orskov H. Ipamorelin, a new growth-hormone-releasing peptide, induces longitudinal bone growth in rats. Growth Horm IGF Res. 1999 Apr;9(2):106-13. doi: 10.1054/ghir.1999.9998. PMID: 10373343. [Read More]